Munafa Stock Market Course + Intraday & FNO calls 
Akari Therapeutics (AKTX) Technical (Analysis) Reports Akari Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Akari Therapeutics (AKTX)
Technical Analysis Report for USA stock AKTX Akari Therapeutics. Dated: 10 Jul 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock AKTX Akari Therapeutics then click here. or read Experts views on Akari Therapeutics or Forecast & share price targets of Akari Therapeutics
Akari Therapeutics Opened at 13.04 and Closed at: 13.84, which is 6.5% of previous session's close. It moved within a range of 12.50 and 13.89
The session was a Bullish session with an average volume of 42659, which is 75.31% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
- The stock has shown an up move, and its mid term trend is also positive and in an uptrend.
- The stock has shown an up move, and its long term trend is also positive and in an uptrend.
Support for tomorrow is 13.17 and resistance for tomorrow is 14.56
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 12.93, 12.02 resistance for tomorrow's hourly charts is 14.32, 14.8
10 Day SMA for Akari Therapeutics (AKTX) is 11.81 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Akari Therapeutics (AKTX) is 11.94 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Akari Therapeutics (AKTX) is 10.59 and the stock is trading above these levels. This is a good sign for its mid to long term trend
100 Day SMA is 6.39 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Akari Therapeutics is 3.45 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Akari Therapeutics is at 11.94 and 200 DMA is at 3.45, while 50 DMA and 100 DMA are at 10.59 and 6.39 respectively
Akari Therapeutics (AKTX) moving average of 20 SMA is at 11.94 and 20 EMA is at 12.17
| Date | Closing Price | 20 SMA | 20 EMA |
| 10 Fri Jul | 13.84 | 11.94 | 12.17 |
| 09 Thu Jul | 12.94 | 11.98 | 11.99 |
| 08 Wed Jul | 13.78 | 12.08 | 11.89 |
| 07 Tue Jul | 15.35 | 12.16 | 11.69 |
| 06 Mon Jul | 10.90 | 12.15 | 11.3 |
| 02 Thu Jul | 10.41 | 12.4 | 11.34 |
Akari Therapeutics (AKTX) moving average of 50 SMA is at 10.59 and 50 EMA is at 10.5
| Date | Closing Price | 50 SMA | 50 EMA |
| 10 Fri Jul | 13.84 | 10.59 | 10.5 |
| 09 Thu Jul | 12.94 | 10.42 | 10.36 |
| 08 Wed Jul | 13.78 | 10.28 | 10.25 |
| 07 Tue Jul | 15.35 | 10.11 | 10.11 |
| 06 Mon Jul | 10.90 | 9.92 | 9.9 |
| 02 Thu Jul | 10.41 | 9.82 | 9.86 |
Akari Therapeutics (AKTX) moving average of 100 SMA is at 6.39 and 100 EMA is at 7.83
| Date | Closing Price | 100 SMA | 100 EMA |
| 10 Fri Jul | 13.84 | 6.39 | 7.83 |
| 09 Thu Jul | 12.94 | 6.26 | 7.71 |
| 08 Wed Jul | 13.78 | 6.13 | 7.6 |
| 07 Tue Jul | 15.35 | 6 | 7.48 |
| 06 Mon Jul | 10.90 | 5.84 | 7.32 |
| 02 Thu Jul | 10.41 | 5.74 | 7.25 |
Akari Therapeutics (AKTX) moving average of 200 SMA is at 3.45 and 200 EMA is at 5.22
| Date | Closing Price | 200 SMA | 200 EMA |
| 10 Fri Jul | 13.84 | 3.45 | 5.22 |
| 09 Thu Jul | 12.94 | 3.39 | 5.13 |
| 08 Wed Jul | 13.78 | 3.33 | 5.05 |
| 07 Tue Jul | 15.35 | 3.26 | 4.96 |
| 06 Mon Jul | 10.90 | 3.19 | 4.86 |
| 02 Thu Jul | 10.41 | 3.14 | 4.8 |
Community Health has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Community Health, about 23.66% more returns!
Supernus Pharmaceuticals has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Supernus Pharmaceuticals, about 12.98% more returns!
Neuronetics Inc has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Neuronetics Inc, about 40.7% more returns!
Rhythm Pharmaceuticals has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Rhythm Pharmaceuticals, about 30.27% more returns!
Oramed Pharmaceuticals has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Oramed Pharmaceuticals, about 12.93% more returns!
Minerva Neurosciences has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Minerva Neurosciences, about 9.21% more returns!
Akari Therapeutics has performed better than Mustang Bio in short term. Holding Akari Therapeutics could be a better choice for now!
Atyr Pharma has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Atyr Pharma, about 23.61% more returns!
Akari Therapeutics has performed better than Lifevantage Corporation in short term. Holding Akari Therapeutics could be a better choice for now!
Iovance Biotherapeutics has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Iovance Biotherapeutics, about 13.16% more returns!
Esperion Therapeutics has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Esperion Therapeutics, about 7.88% more returns!
Collegium Pharmaceutical has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Collegium Pharmaceutical, about 9.17% more returns!
Cellectis S has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Cellectis S, about 3.37% more returns!
Akari Therapeutics has performed better than Atossa Genetics in short term. Holding Akari Therapeutics could be a better choice for now!
Assembly Biosciences has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Assembly Biosciences, about 28.31% more returns!
Arrowhead Pharmaceuticals has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Arrowhead Pharmaceuticals, about 9.3% more returns!
Amneal Pharmaceuticals has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Amneal Pharmaceuticals, about 10.65% more returns!
Aldeyra Therapeutics has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Aldeyra Therapeutics, about 27.66% more returns!
Abeona Therapeutics has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Abeona Therapeutics, about 32.6% more returns!
Akari Therapeutics Technical analysis of indicators
Price action analysis of Akari Therapeutics (AKTX) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Akari Therapeutics stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Akari Therapeutics in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Akari Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Akari Therapeutics in short term and BUY signal is strong.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Akari Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 11.11 and Akari Therapeutics AKTX stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Akari Therapeutics AKTX stock. Volume based technical analysis of Akari Therapeutics AKTX stock is negative.
Akari Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock AKTX Akari Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And AKTX Experts View which covers a lot of information including buying and selling signals
AKTX future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Akari Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Akari Therapeutics (AKTX) Technical (Analysis) Reports Akari Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
